```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the OTC Hydrotalcite Chewable Tablets market with a 35% share, driven by high adoption of OTC remedies, robust healthcare infrastructure, and strong consumer awareness. Regulatory support for over-the-counter accessibility and investments in digital health ecosystems further fuel demand."
},
{
"type": "paragraph",
"content": "Europe follows with a 25% share, bolstered by mature healthcare policies, aging demographics, and rising preference for chewable dosage forms. Stringent quality standards and cross-border collaborations enhance market penetration."
},
{
"type": "paragraph",
"content": The Asia Pacific region is the fastest-growing market (CAGR 8.5%), fueled by expanding middle-class populations, urbanization, and increasing government initiatives to improve digestive health awareness. Infrastructure investments and partnerships with global players accelerate adoption."
},
{
"type": "paragraph",
"content": "In Latin America, a 10% share is attributed to growing OTC market liberalization, rising disposable incomes, and improved distribution networks. However, fragmented regulatory frameworks remain a challenge."
},
{
"type": "paragraph",
"content": "Middle East & Africa holds an 8% share, with growth linked to urbanization, expanding pharma investments, and rising health consciousness. Public-private partnerships aim to enhance OTC accessibility in underpenetrated areas."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 25 },
{ "name": "Asia Pacific", "value": 22 },
{ "name": "Latin America", "value": 10 },
{ "name": "Middle East & Africa", "value": 8 }
]
}
}
```
